Skip to main content

"POTENCIACION DE LA REMIELINIZACION ESPONTANEA EN LA ESCLEROSIS MULTIPLE: OLIGODENDROGLIOGENESIS Y MIELINIZACION"

SAF2016-77575-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2016
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cajal and the Spanish School of Neurology: Neuroscience would have been a different story without them.

  • Castro Soubriet, Fernando de
Santiago Ramón y Cajal was still young when he came across the reazione nera, discovered by the Italian Camillo Golgi. Cajal became absolutely entranced by the fine structure of the nervous system this technique revealed, which led him to embark on one of the last truly epic endeavors in Modern History: the characterization of nervous cells, and of their organization to form the brain. Cajal remained in Spain throughout his scientific career, working for years alone. With international recognition, Cajal began recruiting brilliant students as collaborators. A handful of his pupils also made decisive discoveries that served to lay the foundations of modern Neuroscience. Cajal’s brother Pedro, Tello, Domingo Sánchez, Achúcarro, Lafora, Río-Hortega, de Castro and Lorente de Nó worked side by side with El Maestro. While Cajal himself pronounced some of the basic rules that have helped us to understand the nervous system (the neuron theory, the law of dynamic polarization of the neuron), as well as providing innumerable details about the histological organization of the different neural structures, it was Pío del Río-Hortega who identified two of the four main cell types in the CNS (oligodendrocytes and microglia), and Fernando de Castro who described the innervation of the blood vessels and identified the first chemoreceptors in the carotid body. Together, this group of scientists is known as the Spanish Neurological School, and if they had not existed, the History of Neuroscience would surely have been quite a different story; and proof that Cajal was a truly exceptional scientist but he was not an exception for Spanish Science., This study was supported by the Spanish Ministry of Science (former Ministry of Economy; grants SAF2016-77575-R and RD16/0015/0019), the regional government of Comunidad de Madrid (Grant IND2018/BMD-9751), the Fundación Inocente Inocente (Spain), and Fundación Ramón Areces (Spain
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The presence and suppressive activity of Myeloid-Derived Suppressor Cells are potentiated after Interferon-ß treatment in a murine model of Multiple Sclerosis

  • Melero-Jerez, Carolina
  • Suardíaz, Margarita
  • Lebrón-Galán, Rafael
  • Marín-Bañasco C
  • Oliver-Martos, Begoña
  • Machín-Díaz, Isabel
  • Fernández, Óscar
  • Castro Soubriet, Fernando de
  • Clemente, Diego
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the human central nervous system (CNS), mainly affecting young adults. Among the immunomodulatory disease modifying treatments approved up to date to treat MS, IFN-β remains to be one of the most widely prescribed for the Relapsing-Remitting (RR) variant of the disease, although its mechanism of action is still partially understood. RR-MS variant is characterized by phases with increasing neurological symptoms (relapses) followed by periods of total or partial recovery (remissions), which implies the existence of immunomodulatory agents to promote the relapsing-to-remitting transition. Among these agents, it has been described the immunosuppressive role of a heterogeneous population of immature myeloid cells, namely the myeloid-derived suppressor cells (MDSCs) during the clinical course of the experimental autoimmune encephalomyelitis (EAE), the most used MS model to study RRMS. However, it is still unknown how the current MS disease modifying treatments, e.g. IFN- β, affects to MDSCs number or activity. Our present results show that a single injection of IFN-β at the onset of the clinical course reduces the severity of the EAE, enhancing the presence of MDSCs within the smaller demyelinated areas. Moreover, the single dose of IFN-β promotes MDSC immunosuppressive activity both in vivo and in vitro, augmenting T cell apoptosis. Finally, we show that IFN-ß preserves MDSC immaturity, preventing their differentiation to mature and less suppressive myeloid cell subsets. Taking together, all these data add new insights into the mechanism of IFN-β treatment in EAE and point to MDSCs as a putative endogenous mediator of its beneficial role in this animal model of MS., This work was supported by the Spanish Ministerio de Economía, Industria y Competitividad-MINEICO (SAF2012-40023; SAF2016-77575-R; RD12-0032-12; RD16-0015-0019; PI15-00963; PI18/00357, partially financed by F.E.D.E.R.: European Union, “Una Manera de hacer Europa”), the Spanish Research Council/Consejo Superior de Investigaciones Científicas-CSIC (CSIC-2015201023), ADEM-TO (Spain) and ARSEP Foundation (France). DC, RL-G and IM-D were financed by SESCAM; CM-J holds a predoctoral Research Training contract from MINEICO (BES-2013-062630, –associated to SAF2012-40023 and PI15-00963) and is currently hired under SAF2016-77577-R. Dr. Clemente's group was sponsored by Aciturri Aeronáutica SLU, Vesuvius Ibérica LA and Fundación Galletas Coral.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The Women Neuroscientists in the Cajal School

  • Giné, Elena
  • Martínez, Carmen
  • Sanz, Carmen
  • Nombela, Cristina
  • Castro Soubriet, Fernando de
At the beginning of the 20th century, in view of the growing international recognition of Santiago Ramón y Cajal, the Spanish authorities took some important steps to support Cajal’s scientific work. This recognition peaked in 1906, when Camillo Golgi and Santiago Ramón y Cajal shared the Nobel Prize in Physiology or Medicine. The Spanish government provided Cajal a state-of-the-art laboratory in Madrid to allow him to continue with his research and they funded salaries to pay his first tenured collaborators, the number of which increased further after the creation of the Junta para Ampliación de Estudios (JAE). The JAE was an organism set up to help promising researchers develop their careers in different ways, thereby contributing to the development of science in Spain. Although largely forgotten or relatively unknown, there has been a recent revival in the recognition of the school that developed around Cajal, collectively referred to as the Spanish Neurological School (or colloquially, as the Cajal School or School of Madrid). Almost all Cajal’s collaborators were men, although a limited number of female scientists spent part of their careers at the heart of the Cajal School. Here we discuss these women and their work in the laboratory in Madrid. We have tracked the careers of Laura Forster (from Australia/United Kingdom), Manuela Serra, María Soledad Ruiz-Capillas and María Luisa Herreros (all Spanish), through their scientific publications, both in the journal founded by Cajal and elsewhere, and from other documentary sources. To complete the picture, we also outline the careers of other secondary figures that contributed to the production and running of Cajal’s laboratory in Madrid. We show here that the dawn of Spanish neuroscience included a number of contributions from female researchers who to date, have received little recognition., This work was supported by grants PIMCD2017-101 and PIMCD2018-168 from the Vicerrectorado de Calidad, Universidad Complutense de Madrid. Boston Scientific Ibérica has funded CN. The research group of FdC is currently supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (Grants SAF2016-77575-R and RD16-0015-0019, partially financed by F.E.D.E.R.: European Union “Una manera de hacer Europa”), the Fundación Ramón Areces (Spain), the Fundación Inocente Inocente (Spain), the Comunidad de Madrid (Spain, Grant No. IND2018/BMD-9751), a supporting technological contract from AptaTargets, S.L. (Spain), and a grant from the Federation of European Neuroscience Societies (FENS) History Online Project Grants Call 2018.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Functional heterogeneity of mouse and human brain OPCs: Relevance for preclinical studies in multiple sclerosis

  • Bribián, Ana
  • Medina-Rodríguez, Eva M.
  • Josa-Prado, Fernando
  • García-Álvarez, Isabel
  • Machín-Díaz, Isabel
  • Esteban, Pedro F.
  • Murcia-Belmonte, Verónica
  • Vega-Zelaya, Lorena
  • Pastor, Jesús
  • Garrido, Leoncio
  • Castro Soubriet, Fernando de
This article belongs to the Special Issue Glial Cells in Central Nervous System (CNS) Pathology and Repair., Besides giving rise to oligodendrocytes (the only myelin-forming cell in the Central Nervous System (CNS) in physiological conditions), Oligodendrocyte Precursor Cells (OPCs) are responsible for spontaneous remyelination after a demyelinating lesion. They are present along the mouse and human CNS, both during development and in adulthood, yet how OPC physiological behavior is modified throughout life is not fully understood. The activity of adult human OPCs is still particularly unexplored. Significantly, most of the molecules involved in OPC-mediated remyelination are also involved in their development, a phenomenon that may be clinically relevant. In the present article, we have compared the intrinsic properties of OPCs isolated from the cerebral cortex of neonatal, postnatal and adult mice, as well as those recovered from neurosurgical adult human cerebral cortex tissue. By analyzing intact OPCs for the first time with 1H High Resolution Magic Angle Spinning Nuclear Magnetic Resonance (1H HR-MAS NMR) spectroscopy, we show that these cells behave distinctly and that they have different metabolic patterns in function for their stage of maturity. Moreover, their response to Fibroblast Growth Gactor-2 (FGF-2) and anosmin-1 (two molecules that have known effects on OPC biology during development and that are overexpressed in individuals with Multiple Sclerosis (MS)) differs in relation to their developmental stage and in the function of the species. Our data reveal that the behavior of adult human and mouse OPCs differs in a very dynamic way that should be very relevant when testing drugs and for the proper design of effective pharmacological and/or cell therapies for MS., This research was funded by the Spanish Ministerio de Ciencia, Innovación y Universidades (former Ministerio de Economía y Competitividad-MINECO: grant numbers SAF2009–07842, ADE10-0010, SAF2012-40023, SAF2016-77575-R, and the Red Española de Esclerosis Múltiple: RD12-0032-12; RD16/0015/0019), Spanish Research Council-CSIC (grant number PID2019-109858RB-100), the ‘‘Fundación Eugenio Rodríguez Pascual’’ (Spain) and the “Fundación Ramón Areces” (grant number CIVP19A5917). The APC was funded by grants SAF2016-77575-R and PID2019-109858RB-100.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fernando de Castro: Cajal's Man on the Peripheral Nervous System

  • Ros-Bernal, F
  • Castro Soubriet, Fernando de
Santiago Ramón y Cajal developed his initial scientific career working alone. After the publication of his opus magna (“Textura del sistema nervioso del hombre y los vertebrados”) and the general recognition of the scientific environments that crystallized with the concession of the International Moscow Prize (1900), the Spanish Government decided to officially support Cajal with a laboratory and the first salaries to pay collaborators. Is then when the Spanish Neurological School births: in 1902, Francisco Tello is the first one to be incorporated. With new additions, Cajal's work is complimented in new aspects, including Neuropathologies. Fernando de Castro is one of his youngest direct disciples, one of the closest and more beloved. Fernando de Castro worked from 1916 in Cajal's lab, until the death of El Maestro. He was specially committed by Cajal to unravel different aspects of the structure of the peripheral ganglia: sensitive and vegetative. Afterward, Fernando de Castro described by first time the nature of arterial chemoreceptors in the carotid body. While trying to confirm his anatomical description with physiological demonstrations, and accumulating delays because of scientific decision and the sociopolitical circumstances in Spain, Corneille Heymans was awarded with the Nobel Prize in Physiology or Medicine 1938 for his contributions to the knowledge of cardiorespiratory reflexes. The Karolinska Institutet forgot Heinrich Hering and Fernando de Castro in their decision. Undoubtedly, Fernando de Castro was the most important disciple of Cajal working in the different structures of the peripheral nervous system, and this work is now reviewed here. Anat Rec, 303:1206–1214, 2020. © 2019 American Association for Anatomy, FdC research group is currently financed by the Spanish Ministry of Science (former Ministry of Economy; Grants SAF2016-77575-R and RD16/0015/0019 partially cofinanced by FEDER “Una manera de hacer Europa”) and Fundación Inocente Inocente (Spain).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Myeloid-derived suppressor cells support remyelination in a murine model of Multiple Sclerosis by promoting oligodendrocyte precursor cell survival, proliferation and differentiation

  • Melero-Jerez, Carolina
  • Fernández-Gómez, Beatriz
  • Lebrón-Galán, Rafael
  • Ortega, María C.
  • Sánchez-de Lara, I.
  • Ojalvo-Sanz, Ana Cristina
  • Clemente, Diego
  • Castro Soubriet, Fernando de
The most frequent variant of multiple sclerosis (MS) is the relapsing-remitting form, characterized by symptomatic phases followed by periods of total/partial recovery. Hence, it is possible that these patients can benefit from endogenous agents that control the inflammatory process and favor spontaneous remyelination. In this context, there is increasing interest in the role of myeloid-derived suppressor cells (MDSCs) during the clinical course of experimental autoimmune encephalomyelitis (EAE). MDSCs speed up infiltrated T-cell anergy and apoptosis. In different animal models of MS, a milder disease course is related to higher presence/density of MDSCs in the periphery, and smaller demyelinated lesions in the central nervous system (CNS). These observations lead us to wonder whether MDSCs might not only exert an anti-inflammatory effect but might also have direct influence on oligodendrocyte precursor cells (OPCs) and remyelination. In the present work, we reveal for the first time the relationship between OPCs and MDSCs in EAE, relationship that is guided by the distance from the inflammatory core. We describe the effects of MDSCs on survival, proliferation, as well as potent promoters of OPC differentiation toward mature phenotypes. We show for the first time that osteopontin is remarkably present in the analyzed secretome of MDSCs. The ablation of this cue from MDSCs-secretome demonstrates that osteopontin is the main MDSC effector on these oligodendroglial cells. These data highlight a crucial pathogenic interaction between innate immunity and the CNS, opening ways to develop MDSC- and/or osteopontin-based therapies to promote effective myelin preservation and repair in MS patients., This work was supported by the Spanish Ministerio de Economía, Industria y Competitividad-MINEICO (currently Ministerio de Ciencia e Innovación: grants SAF2012-40023, SAF2015-72325-EXP, SAF2016-77575-R, and PID2019-109858RB-I00); the Instituto de Salud Carlos III (grants RD12-0032-12, RD16-0015-0019, PI15-00963, and PI18-00357—partially financed by F.E.D.E.R.: European Union “Una manera de hacer Europa”-); the Spanish Research Council/Consejo Superior de Investigaciones Científicas-CSIC (grants CSIC-2015201023, 2019AEP033, and LINKA20268); and ADEM-TO (Spain), ATORDEM (Spain), AELEM (Spain), and ARSEP Foundations (France). D. C. and R. L. G. were financed by SESCAM. C. M.-J. held a BES-2013-062630 predoctoral Research Training contract from MINEICO (associated with SAF2012-40023 and PI15-00963) and a contract under SAF2015-72325-EXP and SAF2016-77575-R. B. F.-G. is currently contracted under IND2018/BMD-9751 (Comunidad de Madrid, Spain). M. C. O holds a postdoctoral contract from the Consejería de Sanidad de Castilla-La Mancha (II-2018_07). Dr Clemente's group was sponsored by Aciturri Aeronáutica SLA, Fundación Galletas Coral, and Embutidos y Jamones España e Hijos.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Supporting central nervous system neuroprotection and remyelination by specific TLR4 antagonism

  • Fernández-Gómez, Beatriz
  • Marchena, Miguel A.
  • Piñeiro, David
  • Laó, Yolanda
  • Valencia, Gloria
  • Nocera, Sonia
  • Benítez-Fernández, Rocío
  • Gómez-Martín, Paula
  • Castaño-León, Ana M.
  • Lagares, Alfonso
  • Hernández-Jiménez, Macarena
  • Castro Soubriet, Fernando de
ApTOLL is an aptamer specifically designed to antagonize toll-like receptor 4 (TLR4), which is involved in the innate immunity that promotes inflammatory responses in several diseases, including multiple sclerosis (MS). MS is a chronic, immune, demyelinating and neurodegenerative disease of the central nervous system that represents the second most important cause of neurological disability in young adults. The drugs currently available to treat this disease are immunomodulators and, to date, there are no therapeutic remyelinating drugs available to manage MS. In this study, we show that TLR4 is located in post-mortem cortical lesions of MS patients and as a result, we evaluated the effect of its inhibition by ApTOLL in two different animal models of MS, that of experimental autoimmune encephalomyelitis (EAE) and the cuprizone model. ApTOLL administration ameliorated the clinical symptomatology of the affected mice, which was associated with better preservation and restoration of myelin and oligodendrocytes in the demyelinated lesions of these animals. This revealed not only an immunomodulatory but also a remyelinating effect of the treatment with ApTOLL which was corroborated on purified cultures of rodent and adult human oligodendrocyte precursor cells (OPCs). In summary, the molecular nature of ApTOLL and its mechanism of action strongly supports its further study and use in novel strategies to treat MS and eventually, other demyelinating diseases., This work was supported by grant IND2018/BMD-9751 (Programa de Doctorados Industriales, Comunidad de Madrid, Spain), SAF2016-77575-R (Spanish Ministerio de Economía, Industria y Competitividad-MINECO), and the contract for technological support ApTLR2019-PC-MS-001 (AptaTargets, S.L., Spain) to FdC. BF-G is currently hired by Aptatargets S.L., PG-M is hired under PEJ-2020-AI/BMD-18541 de la Comunidad de Madrid, Spain (associated with the youth guarantee fund to FdC), SN had a predoctoral contract from the UCLM and was hired under SAF2012-40023, SAF2016- 77575-R, RD12-0032/0012 and RD16-0015/0019 (Spanish Ministerio de Economía, Industria y Competitividad-MINECO) and IND2018/BMD-9751, YL has been contracted under ReTics and SAF (to FdC). We thank David Segarra and Mª Eugenia Zarabozo (AptaTargets S.L.) for their constant technological support, Laude Garmendia for her indispensable constant help at the animal facility (Instituto Cajal-CSIC), including the extra effort during Covid-19 pandemics, Profs María Ángeles Moro (Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid and Universidad Complutense de Madrid, Spain) and Ignacio Lizasoaín (Universidad Complutense de Madrid, Spain) for lending us the TLR4 knockout mice, and the former GNDe member Dr. Carolina MeleroJerez (currently working at JazzPharma, Spain) for the initial training of BF-G on EAE animal model and different techniques at the laboratory. Human samples were supplied by the UK Multiple Sclerosis Tissue Bank, funded by the Multiple Sclerosis Society of Great Britain and Northern Ireland (registered charity 207495)., No